Pulmonary fungal infection in malignant hematological diseases: an analysis of 14 cases.
- Author:
Qi SHEN
1
;
Xian-Min SONG
;
Xiao-Ping XU
;
Jian-Min WANG
Author Information
1. Department of Hematology, Central Hospital of Yangpu District, Shanghai 200090, China. shengqi9@yahoo.com
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Antifungal Agents;
therapeutic use;
Aspergillosis;
complications;
diagnosis;
drug therapy;
Candidiasis;
complications;
diagnosis;
drug therapy;
Female;
Fluconazole;
therapeutic use;
Hematologic Neoplasms;
drug therapy;
etiology;
pathology;
Humans;
Lung Diseases, Fungal;
complications;
diagnosis;
drug therapy;
Male;
Middle Aged;
Treatment Outcome
- From:
Journal of Experimental Hematology
2005;13(6):1125-1127
- CountryChina
- Language:Chinese
-
Abstract:
The objective of this study was to evaluate the etiological factors, diagnosis and therapy of pulmonary fungal infection in hematological malignancies, 14 cases of malignant hematological disease with pulmonary fungal infection were collected and analyzed. The results showed that 11 out of 14 cases had the respiratory manifestations, sputum was sticky and difficult to be expectorated in 7 cases, X rays in chests showed shadows with features of stigma and sheet in 11 cases, Candida albicans and aspergillus infection were observed in 10 and 2 cases respectively, the numbers of neutrophil were below 0.5 x 10(9)/L in 8 cases and below 1.0 x 10(9)/L in 3 cases respectively, fluconazole was used for 12 cases and clinical symptoms of 11 cases were improved within two weeks. In conclusion, the occurrence of pulmonary fungal infection in malignant hematological diseases is associated with intensive chemotherapy, decrease of neutrophil counts and using of broad-spectrum antibiotics, the diagnosis at early stage is difficult and clinicians should pay more attention to its clinical and laboratory examinations, and give them therapy in time.
